Renol Polychem IPO GMP, Date, Price, Allotment, Review & Listing Details

Renol Polychem Limited IPO is generating significant buzz in the SME segment, with investors actively tracking its Grey Market Premium (GMP) and overall subscription status. The company aims to raise ₹25.77 crores through this IPO, offering strong growth potential and a focused business model. Let’s explore key insights, including IPO dates, price band, allotment, GMP updates, and analysis.

1. Renol Polychem IPO Overview

The Renol Polychem IPO opened for public subscription on July 31, 2025, and will close on August 4, 2025. This ₹25.77 crore issue consists solely of a fresh offer of 24.54 lakh equity shares. The IPO will list on the NSE SME platform. A rising Renol Polychem IPO GMP indicates growing investor confidence and potential for positive listing gains.

2. About Renol Polychem Ltd

Established in 2008 and headquartered in Rajkot, Gujarat, Renol Polychem specializes in the production of polymer compounds, impact modifiers, and masterbatches. These components are critical in the manufacturing of PVC/CPVC pipes, plastic furniture, and packaging items. The company’s manufacturing operations commenced in 2020, backed by advanced infrastructure and modern machinery.

3. Renol Polychem IPO Key Details

• IPO Open Date: July 31, 2025

• IPO Close Date: August 4, 2025

• Price Band: ₹100 – ₹105 per share

• Lot Size: 1,200 shares

• Minimum Retail Investment: ₹2,40,000 (2,400 shares)

• HNI Minimum Investment: ₹3,78,000 (3 lots or 3,600 shares)

• Issue Size: ₹25.77 Cr (100% Fresh Issue)

• Listing Platform: NSE SME

The positive sentiment surrounding the IPO is partly due to an active Renol Polychem IPO GMP, which reflects market enthusiasm.

4. Objective of the Issue

The company plans to utilize the IPO proceeds for:

• Working capital needs

• General corporate purposes

• Covering public issue-related expenses

These funds will enhance the company’s operational capabilities and support its expansion initiatives.

5. Business Model & Product Portfolio

Renol Polychem operates on a B2B model, catering to:

• Pipe manufacturers

• Packaging material producers

• Plastic goods manufacturers

Its product range includes:

• Colour, White, and Black Masterbatches

• Filler Granules & Additives

• Impact Modifiers for CPVC/PVC Applications

The company's diverse product line positions it well in India’s growing construction and plastic sectors.

6. Financial Performance (Recent Years)

The company has delivered consistent growth, with a 19% increase in revenue and 27% jump in net profit in FY24, highlighting operational efficiency.

7. Renol Polychem IPO GMP & Listing Expectations

As of August 2, 2025, the Renol Polychem IPO GMP is ₹18 per share.

• Expected Listing Price: ₹123 (₹105 + ₹18 GMP)

The steady GMP signals healthy demand in the grey market and possible listing gains for early investors.

8. Valuation Analysis & Peer Comparison

• FY24 EPS: ₹7.76

• P/E at upper band ₹105: ~13.53x

• Industry P/E Average: ~20x – 22x

The IPO appears fairly priced, especially considering the company's earnings growth and current GMP, making it attractive to informed SME investors.

9. Key Strengths

• Wide product portfolio

• Robust revenue and profit growth

• Cost-effective manufacturing model

• Pan-India customer base

• Skilled and experienced promoters

10. Risks & Weaknesses

• Reliant on demand cycles in the PVC/CPVC market

• SME stocks carry liquidity risk

• Commercial operations only since 2020

• Highly competitive sector

11. IPO Timeline & Listing Schedule

12. Lot Size & Investment Requirements

13. IPO Reservation Structure

• Retail Quota: 50% of issue

• HNI (NII) Quota: 50% of issue

• QIB Reservation: Not applicable (as per SME norms)

14. Promoters & Shareholding

• Promoters: